Oxaliplatin

hypoxia inducible factor 1 subunit alpha ; Homo sapiens







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33982772 LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway. 2021 Jul 2
2 34740372 Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. 2021 Nov 5 2
3 31477841 Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer. 2020 Jan 3
4 31208913 Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop. 2019 Oct 2 3
5 26931435 Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells. 2016 1
6 26126066 The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy. 2015 1
7 26292288 HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a. 2015 1
8 23071744 Synergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116. 2012 1
9 19755992 Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells. 2009 Oct 20 2